Martin Delaney Collaboratories for HIV Cure Research
Last verified by NonDilute: 2026-06-08. Official notice and agency instructions control.
If you lead an established research team or institution with HIV cure expertise and can assemble a multidisciplinary consortium, this NIH collaboratory program offers substantial funding and network support.
Report stale or inaccurate summary
What this is
The Martin Delaney Collaboratories program is an NIH initiative (CFDA 93.855) designed to fund collaborative research consortia tackling HIV cure research. This is a team-science program emphasizing cross-disciplinary collaboration rather than individual investigator grants. Eligibility criteria and budget details are not fully specified in the provided materials, but this typically targets established research institutions, academic medical centers, and research organizations with infrastructure to support large multi-site teams.
Who can apply
Eligibility criteria are unspecified in the source material. Historically, Martin Delaney Collaboratories require applicants to be research institutions, universities, or established non-profits with proven capacity to manage multi-site collaborative teams and HIV research infrastructure. Solo founders and early-stage startups are unlikely to be eligible.
Topics: HIV cure research · collaboratory grant · translational research · clinical trials · team science · NIH funding
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.